Bayer AG

Bayer AG is a German multinational pharmaceutical company and life sciences company headquartered in Leverkusen, North Rhine-Westphalia, Germany. Founded in 1863 by Friedr. Bayer & Co., the company has a long history of innovation and has grown to become one of the largest and most successful pharmaceutical companies in the world. With a diverse portfolio of products and a strong presence in research and development, Bayer AG is a leading player in the global healthcare industry. The company's mission is to "Science for a better life" and it operates in over 300 countries worldwide.

History

Bayer AG was founded in 1863 by Friedr. Bayer & Co., a small dyestuffs factory in Barmen, Germany. The company quickly grew and became known for its innovative products, including aspirin, which was first marketed by Bayer in 1899. During World War I, Bayer produced Zyklon B, a toxic gas used in concentration camps during the Holocaust. After the war, the company continued to grow and expand its product portfolio, including the development of polyurethane and polyvinyl chloride (PVC). In 1925, Bayer merged with several other German companies to form IG Farben, a chemical conglomerate that played a significant role in the German war effort during World War II. After the war, IG Farben was dissolved and Bayer was re-established as an independent company.

Corporate structure and operations

Bayer AG is a publicly traded company listed on the Frankfurt Stock Exchange and is a DAX component. The company is headquartered in Leverkusen, North Rhine-Westphalia, Germany and has operations in over 300 countries worldwide. Bayer has a decentralized corporate structure, with several subsidiaries and divisions operating independently. The company's Board of Management is responsible for strategic decision-making and is composed of several members, including the Chief Executive Officer (CEO). Bayer also has a Supervisory Board, which oversees the company's management and provides guidance on strategic decisions.

Products and divisions

Bayer AG has a diverse portfolio of products and operates in several divisions, including pharmaceuticals, consumer health, animal health, and plant science. The company's pharmaceutical division is one of the largest in the world and produces a range of products, including Xarelto, Eylea, and Kogenate FS. Bayer's consumer health division produces a range of over-the-counter medications, including Aspirin, Alka-Seltzer, and Claritin. The company's animal health division produces a range of products for veterinary care, including Baytril and Marbocyl. Bayer's plant science division develops and markets a range of products for crop protection, including Roundup and Decis.

Controversies and legal issues

Bayer AG has faced several controversies and legal issues over the years, including criticism over its role in the Holocaust and its production of Zyklon B. In 2019, the company agreed to pay $10.6 billion to settle claims related to its acquisition of Monsanto Company, which had been linked to several lawsuits over the use of glyphosate-based herbicides. Bayer has also faced criticism over its handling of the opioids crisis in the United States and has been sued by several states over its marketing and distribution of opioids.

Financial performance

Bayer AG has a strong financial performance, with revenues of over €46 billion in 2020. The company's pharmaceutical division is one of the largest contributors to its revenue, followed by its consumer health and animal health divisions. Bayer has a significant presence in emerging markets, including China, India, and Brazil, which are expected to drive future growth. The company has also invested heavily in research and development, with a focus on developing new products and technologies in the life sciences sector. Category:Pharmaceutical companies of Germany